We are currently assessing the safety and efficacy of an investigational medication in the treatment of persistent pain following the occurrence of Shingles (Herpes-Zoster). To be eligible for the study, participants must:

• Have pain present for at least 3 months after the disappearance of the rash.

The investigational medication, study-related evaluations, and laboratory tests will be provided to qualified participants at no cost.

For more information please contact:

Jaime Latorre, M.D.
Email: jlatorre@drkudrow.com

2001 Santa Monica Blvd. Suite 880W, Santa Monica, CA 90404
Tel: (310) 315-1456 | Fax: (310) 315-1486